| 产品详情 |
| Edit |   |
|---|
| Product Name | TCS 46b |
|---|
| Description | Orally active, subtype-selective GluN1A/GluN2B (formally NR1A/NR2B) NMDA receptor antagonist (IC50 values are 5.3, 35000 and > 100000 nM for GluN1A/2B (NR1A/2B), GluN1A/2B (NR1A/2B) and GluN1A/2C (NR1A/2C) receptor subtypes respectively). Potentiates the effect of L-DOPA in 6-OHDA-lesioned rats following oral administration. Please refer to IUPHAR Guide to Pharmacology for the most recent naming conventions. Purity 98%. MW (observed): 345.44 |
|---|
| Size | 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 1,3-Dihydro-5-[3-[4-(phenylmethyl)-1-2H-benzimidazol-2-one |
|---|
| Gene, Accession, CAS # | CAS: 302799-86-6 |
|---|
| Catalog # | 2782/50 |
|---|
| Price | |
|---|
| Order / More Info | TCS 46b from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 22950043 |
|---|
| 产品资料 |
|
|